Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

[Impact of treatment with acetylcholinesterase inhibitors, valproic acid and antipsychotics on aggressive behaviour in Alzheimer's type dementia].

Bidzan L, Grabowski J, Dutczak B, Bidzan M.

Psychiatr Pol. 2012 May-Jun;46(3):361-72. Polish.

PMID:
23045890
3.

Aggressive and impulsive behavior in Alzheimer's disease and progression of dementia.

Bidzan L, Bidzan M, Pąchalska M.

Med Sci Monit. 2012 Mar;18(3):CR182-9.

4.
5.

Behavioral and psychological symptoms and the progression of dementia of the Alzheimer type in nursing home residents.

Bidzan L, Pachalska M, Grochmal-Bach B, Bidzan M, Jastrzebowska G.

Med Sci Monit. 2008 Nov;14(11):CR559-67.

PMID:
18971872
6.

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

Neurology. 1998 May;50(5):1222-30.

PMID:
9595967
8.
9.
10.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
11.
12.
13.

Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.

Riepe MW, Adler G, Ibach B, Weinkauf B, Tracik F, Gunay I.

Dement Geriatr Cogn Disord. 2007;23(5):301-6. Epub 2007 Mar 13.

PMID:
17356273
14.
15.

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.

Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M.

J Clin Pharm Ther. 2003 Feb;28(1):53-9.

PMID:
12605619
16.

[Preliminary pilot study of cyproterone acetate for the treatment of aggressive behavior associated with severe dementia].

Caparros-Lefebvre D, Dewailly D.

Rev Neurol (Paris). 2005 Nov;161(11):1071-8. French.

PMID:
16288172
17.

A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.

Chu LW, Yik PY, Mok W, Chung CP.

Int J Clin Pract. 2007 Mar;61(3):403-10.

PMID:
17313606
19.

Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study.

Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators.

J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554.

PMID:
21258153
20.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990

Supplemental Content

Support Center